198 related articles for article (PubMed ID: 11393125)
21. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
Kadir RA; Economides DL
Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].
Go AT; Hupkes HW; Lomecky M; Twisk J; Blankenstein JM; van Vugt JM
Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2795-9. PubMed ID: 16385832
[TBL] [Abstract][Full Text] [Related]
23. First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling.
Brambati B; Cislaghi C; Tului L; Alberti E; Amidani M; Colombo U; Zuliani G
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):9-14. PubMed ID: 7850598
[TBL] [Abstract][Full Text] [Related]
24. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland].
Tercanli S; Holzgreve W; Batukan C; Gerber A; Ermis H; Miny P
Ultraschall Med; 2002 Feb; 23(1):22-6. PubMed ID: 11842368
[TBL] [Abstract][Full Text] [Related]
25. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
[TBL] [Abstract][Full Text] [Related]
26. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
27. Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation.
Hsu JJ; Hsieh CC; Chiang CH; Lo LM; Hsieh TT
Chang Gung Med J; 2003 Jan; 26(1):12-9. PubMed ID: 12656304
[TBL] [Abstract][Full Text] [Related]
28. [Distribution and normal reference range of fetal nuchal translucency thickness in Kunming pregnant women in the first trimester].
Sun Q; Xu J; Hu SQ; Chen M; Ma RM; Lau TK; Zhang L; Xiao X; Qian Y; Guo Z
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):514-7. PubMed ID: 23141162
[TBL] [Abstract][Full Text] [Related]
29. [Echographic measuring of the length of the fetal femur in the screening for Down syndrome].
Biagiotti R; Periti E; Cariati E; Nannini R
Minerva Ginecol; 1992 Dec; 44(12):609-12. PubMed ID: 1491768
[TBL] [Abstract][Full Text] [Related]
30. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.
Wald NJ; Hackshaw AK
Prenat Diagn; 1997 Sep; 17(9):821-9. PubMed ID: 9316126
[TBL] [Abstract][Full Text] [Related]
31. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
Adekunle O; Gopee A; el-Sayed M; Thilaganathan B
Br J Radiol; 1999 May; 72(857):457-60. PubMed ID: 10505009
[TBL] [Abstract][Full Text] [Related]
32. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
33. Screening for fetal chromosomal abnormalities with nuchal translucency measurement in the first trimester.
Has R; Kalelioglu I; Ermis H; Ibrahimoglu L; Yuksel A; Yildirim A; Basaran S
Fetal Diagn Ther; 2006; 21(4):355-9. PubMed ID: 16757911
[TBL] [Abstract][Full Text] [Related]
34. First trimester, second trimester, and integrated screening for Down's syndrome in China.
Miao ZY; Liu X; Shi TK; Xu Y; Song QH; Tang SH
J Med Screen; 2012 Jun; 19(2):68-71. PubMed ID: 22653574
[TBL] [Abstract][Full Text] [Related]
35. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
[TBL] [Abstract][Full Text] [Related]
36. Down's syndrome screening in pregnancies after assisted reproductive techniques: an update.
Maymon R; Jauniaux E
Reprod Biomed Online; 2002; 4(3):285-93. PubMed ID: 12709282
[TBL] [Abstract][Full Text] [Related]
37. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness].
Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A
Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032
[TBL] [Abstract][Full Text] [Related]
38. Distribution of nuchal translucency thickness at 11 to 14 weeks of gestation in a normal Turkish population.
Dinç G; Eyüboğlu İ
Turk J Med Sci; 2021 Feb; 51(1):90-94. PubMed ID: 32777901
[TBL] [Abstract][Full Text] [Related]
39. Nuchal translucency in normal fetuses in a Thai population.
Panburana P; Jaovisidh A; Ajjimakorn S; Tungkajiwangoon P
J Med Assoc Thai; 2002 Feb; 85(2):245-9. PubMed ID: 12081126
[TBL] [Abstract][Full Text] [Related]
40. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
